WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect - the Danish experience

被引:4
作者
Madelung, Ann B. [1 ]
Bondo, Henrik [1 ]
Stamp, Inger [1 ]
Lovgreen, Preben [2 ]
Nielsen, Signe L. [3 ]
Falensteen, Anne [3 ]
Knudsen, Helle [3 ]
Svendsen, Kira D. [4 ]
Lange, Theis [4 ]
Ralfkiaer, Elisabeth [5 ]
Nielsen, Karsten [1 ]
Hasselbalch, Hans [6 ]
Thiele, Juergen [7 ]
机构
[1] Naestved & Slagelse Hosp, Dept Pathol, DK-4700 Naestved, Denmark
[2] Roskilde & Koge Hosp, Dept Pathol, Roskilde, Denmark
[3] Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark
[4] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Dept Pathol, Copenhagen, Denmark
[6] Roskilde & Koge Hosp, Dept Haematol, Roskilde, Denmark
[7] Univ Cologne, Inst Pathol, Cologne, Germany
关键词
Learning effect; interobserver agreement; myeloproliferative neoplasms; workshop; multiheaded microscope; WORLD-HEALTH-ORGANIZATION; BONE-MARROW FIBROSIS; ESSENTIAL THROMBOCYTHEMIA; PRIMARY MYELOFIBROSIS; EUROPEAN CONSENSUS; DIAGNOSIS; RUXOLITINIB; PATHOLOGY; SURVIVAL; CRITERIA;
D O I
10.1111/apm.12417
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the learning effect of a workshop for Danish hematopathologists led by an international expert regarding histological subtyping of myeloproliferative neoplasms (MPN). Six hematopathologists evaluated 43 bone marrow (BM) biopsies according to the WHO description (2008), blinded to clinical data. All panelists then participated in the workshop. The case biopsies - mixed with 251 other MPN BM biopsies - were reviewed again. Consensus regarding the histological subtype was significantly improved; from 49% to 72% (Fleiss kappa value 0.302 pre-workshop, 0.474 post-workshop; p=0.004). There was no significant effect on the isolated morphological characteristics. Agreement between cases with histological consensus and clinical diagnosis was 86% without significant change during workshop sessions. Our study demonstrates that experienced hematopathologists can significantly improve their diagnostic ability by a workshop led by an international expert; not by improving the evaluation of individual histological parameters but by weighting these in their conclusive diagnosis.
引用
收藏
页码:787 / 792
页数:6
相关论文
共 25 条
[21]   The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes [J].
Vardiman, James W. ;
Thiele, Juergen ;
Arber, Daniel A. ;
Brunning, Richard D. ;
Borowitz, Michael J. ;
Porwit, Anna ;
Harris, Nancy Lee ;
Le Beau, Michelle M. ;
Hellstrom-Lindberg, Eva ;
Tefferi, Ayalew ;
Bloomfield, Clara D. .
BLOOD, 2009, 114 (05) :937-951
[22]   Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis [J].
Vener, Claudia ;
Fracchiolla, Nicola Stefano ;
Gianelli, Umberto ;
Calori, Rossella ;
Radaelli, Franca ;
Iurlo, Alessandra ;
Caberlon, Sabrina ;
Gerli, Giancarla ;
Boiocchi, Leonardo ;
Deliliers, Giorgio Lambertenghi .
BLOOD, 2008, 111 (04) :1862-1865
[23]   Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls [J].
Verstovsek, Srdan ;
Kantarjian, Hagop M. ;
Estrov, Zeev ;
Cortes, Jorge E. ;
Thomas, Deborah A. ;
Kadia, Tapan ;
Pierce, Sherry ;
Jabbour, Elias ;
Borthakur, Gautham ;
Rumi, Elisa ;
Pungolino, Ester ;
Morra, Enrica ;
Caramazza, Domenica ;
Cazzola, Mario ;
Passamonti, Francesco .
BLOOD, 2012, 120 (06) :1202-1209
[24]   A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis [J].
Verstovsek, Srdan ;
Mesa, Ruben A. ;
Gotlib, Jason ;
Levy, Richard S. ;
Gupta, Vikas ;
DiPersio, John F. ;
Catalano, John V. ;
Deininger, Michael ;
Miller, Carole ;
Silver, Richard T. ;
Talpaz, Moshe ;
Winton, Elliott F. ;
Harvey, Jimmie H., Jr. ;
Arcasoy, Murat O. ;
Hexner, Elizabeth ;
Lyons, Roger M. ;
Paquette, Ronald ;
Raza, Azra ;
Vaddi, Kris ;
Erickson-Viitanen, Susan ;
Koumenis, Iphigenia L. ;
Sun, William ;
Sandor, Victor ;
Kantarjian, Hagop M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :799-807
[25]   Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes [J].
Wilkins, Bridget S. ;
Erber, Wendy N. ;
Bareford, David ;
Buck, Georgina ;
Wheatley, Keith ;
East, Clare L. ;
Paul, Beverley ;
Harrison, Claire N. ;
Green, Anthony R. ;
Campbell, Peter J. .
BLOOD, 2008, 111 (01) :60-70